Research graph
References from The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenström macroglobulinemia-associated cold agglutinin syndrome. Local targets link to admitted publications; unresolved targets remain external evidence.
Primary chronic cold agglutinin disease: a population based clinical study of 86 patients
2006 · External reference
B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins)
10.1016/0002-9343(82)90852-x · 1982 · External reference
Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
10.1016/j.blre.2012.01.002 · 2012 · External reference
The changing landscape of autoimmune Hemolytic Anemia
10.3389/fimmu.2020.00946 · 2020 · External reference
Cold agglutinin disease: current challenges and future prospects
10.2147/jbm.s177621 · 2019 · External reference
Clinical diversity and treatment outcomes in IgM monoclonal gammopathy associated with cold agglutinin disease and cryoglobulinemia: a single center study
10.59854/dhrrh.2025.3.2.61 · 2025 · External reference
Increased risk of thrombotic events in cold agglutinin disease: a 10-year retrospective analysis
10.1002/rth2.12333 · 2020 · External reference
It takes two to thrombosis: Hemolysis and complement
10.1016/j.blre.2021.100834 · 2021 · External reference
Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan
10.1007/s12185-020-02899-6 · 2020 · External reference
Unresolved reference
2024 · External reference
Cold agglutinin-mediated autoimmune hemolytic anemia
10.1016/j.hoc.2015.01.002 · 2015 · External reference
MYD88 L265P somatic mutation in Waldenström’s macroglobulinemia
10.1056/nejmoa1200710 · 2012 · External reference
Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity
10.3324/haematol.2016.146126 · 2016 · External reference
Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
10.3324/haematol.2013.091702 · 2014 · External reference
Treatment recommendations from the eighth international workshop on Waldenström's macroglobulinemia
10.1182/blood-2016-04-711234 · 2016 · External reference
Report of consensus panel 1 from the 11(th) international workshop on Waldenstrom's macroglobulinemia on management of symptomatic, treatment-naïve patients
10.1053/j.seminhematol.2023.03.005 · 2023 · External reference
Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
10.1182/blood-2003-10-3597 · 2004 · External reference
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
10.1182/blood-2010-06-288647 · 2010 · External reference
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
10.1182/blood-2017-04-778175 · 2017 · External reference
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study
10.1182/blood-2018-03-835413 · 2018 · External reference
Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients
10.1038/s41598-020-69465-2 · 2020 · External reference
Durable responses and favorable cost-effectiveness of rituximab-based chemoimmunotherapy for primary cold agglutinin disease
10.1007/s44313-025-00109-y · 2025 · External reference
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
10.1182/blood.2021012039 · 2021 · External reference
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease
10.1182/bloodadvances.2024012585 · 2024 · External reference
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
10.1182/blood.2021014955 · 2022 · External reference
Unresolved reference
2024 · External reference
Toxicity and response criteria of the eastern cooperative oncology group
10.1097/00000421-198212000-00014 · 1982 · External reference
Unresolved reference
2017 · External reference
Report of consensus panel 4 from the 11th international workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
10.1053/j.seminhematol.2023.03.009 · 2023 · External reference
Impact of chromosomal aberrations detected by chromosome banding analysis in symptomatic Waldenström’s macroglobulinemia
10.1007/s00277-024-06041-y · 2025 · External reference
Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent
10.5045/br.2018.53.2.117 · 2018 · External reference
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
10.1182/blood.2020005674 · 2020 · External reference
Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016-2023
10.1371/journal.pone.0323843 · 2025 · External reference
Cost-effectiveness of sutimlimab in cold agglutinin disease
10.1002/ajh.27358 · 2024 · External reference
